Drug Shortage Report for SANDOZ EZETIMIBE

Last updated on 2017-10-25 History
Report ID 5576
Drug Identification Number 02416778
Brand name SANDOZ EZETIMIBE
Common or Proper name EZETIMIBE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) EZETIMIBE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-03-31
Estimated end date 2017-05-29
Actual end date 2017-05-23
Shortage status Resolved
Updated date 2017-10-25
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-10-25 French Compare
v5 2017-10-25 English Compare
v4 2017-05-08 French Compare
v3 2017-05-08 English Compare
v2 2017-04-04 French Compare
v1 2017-04-04 English Compare

Showing 1 to 6 of 6